Shopping Cart
Remove All
Your shopping cart is currently empty
Indatuximab ravtansine (Synonyms: nBT062-DM4, BT-062)
Catalog No. T9901A-224 Copy Product Info
🥰Excellent
Indatuximab ravtansine (BT-062) is an antibody-drug conjugate (ADC) (Antibody-Drug Conjugates (ADCs)) that consists of a murine-human chimeric form based on B-B4, which specifically targets CD138, linked via a disulfide bond to the maytansinoid drug DM4. It exhibits antitumor activity.
Indatuximab ravtansine
Copy Product Info🥰Excellent
Catalog No. T9901A-224
Synonyms nBT062-DM4, BT-062
Indatuximab ravtansine (BT-062) is an antibody-drug conjugate (ADC) (Antibody-Drug Conjugates (ADCs)) that consists of a murine-human chimeric form based on B-B4, which specifically targets CD138, linked via a disulfide bond to the maytansinoid drug DM4. It exhibits antitumor activity.
Indatuximab ravtansine
Cas No. 1238517-16-2
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Resource Download
Product Introduction
Bioactivity
Antigen Details
Chemical Properties
Storage & Solubility Information
| Description | Indatuximab ravtansine (BT-062) is an antibody-drug conjugate (ADC) (Antibody-Drug Conjugates (ADCs)) that consists of a murine-human chimeric form based on B-B4, which specifically targets CD138, linked via a disulfide bond to the maytansinoid drug DM4. It exhibits antitumor activity. |
| In vitro | Indatuximab ravtansine demonstrated cytotoxic effects in RPMI 8226, MOLP-8, and U266 cell lines (with significant CD138 expression) at concentrations ranging from 1 pM to 100 nM over five days. The IC50 values for RPMI 8226, MOLP-8, and U266 were 200 pM, 40 pM, and 20 pM, respectively. |
| In vivo | Indatuximab ravtansine (5.3-21.2 mg/kg; intravenous injection; single dose) suppresses tumor growth in multiple myeloma and enhances host survival in vivo. |
| Synonyms | nBT062-DM4, BT-062 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Target | CD138 |
| Cas No. | 1238517-16-2 |
| Storage | -20°C for 1 year | Shipping with blue ice. |
Calculator
Preview
Related Tags: buy Indatuximab ravtansine | purchase Indatuximab ravtansine | Indatuximab ravtansine cost | order Indatuximab ravtansine | Indatuximab ravtansine in vivo | Indatuximab ravtansine in vitro
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.